NCT00703352View on ClinicalTrials.gov

Eplerenone in Systemic Right Ventricle

PHASE4CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Transposition of Great VesselsAtrial Switch Procedure

Interventions

DRUG

Eplerenone

Eplerenone (coated tablet) 50mg daily during 12 months.

Trial Locations (1)

08035

Hospital Universitari de la Vall d'Hebron, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER